1-(-1-)- Ӣ 1-butylsulfonylpiperazine ʽ C8H18N2O2S 206.30600 |(zh) 206.10900 PSA 57.79000 LogP 1.36900
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0106088 | 100mg |
1
|
ԃr(ji) |
Q-0106088 | 250mg |
1
|
ԃr(ji) |
Q-0106088 | 500mg |
1
|
ԃr(ji) |
Q-0106088 | 1g |
1
|
ԃr(ji) |
Q-0106088 | 5g |
1
|
ԃr(ji) |

1-(-1-)-Q
1-(-1-)-
Ӣ 1-butylsulfonylpiperazine
ʽ C8H18N2O2S
206.30600
|(zh) 206.10900
PSA 57.79000
LogP 1.36900
P(gun)a(chn)Ʒ
(du)ȱ}} CAS:20265-96-7
(4-Ethoxyphenyl)methanamine CAS:6850-60-8
6-(m-Tolyl)pyridazin-3-amine CAS:113121-50-9
3-Ҵ CAS:73579-06-3
3-(1-)-1,2- CAS:87691-89-2
3'-Hydroxy-[1,1'-biphenyl]-3-carbonitrile CAS:154848-43-8
4-ȼ-2-(3-ȱ)}} CAS:690632-83-8
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
4-p-tolyloxazole Ӣ 4-p-tolyloxazole CAS̖(ho) 54289-71-3 159.18500 ܶ N/A
-
2--4-ױ Ӣ 2-fluoro-4-methyl-1-(trifluoromethyl)benzene ܶ 1.24 c(din) 146 ʽ C8H6F4 178.12700 Wc(din) 39(102F) |(zh) 178.04100 LogP 3.15290 1.4175